Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2026
2025
2024
2023
2022
2021
2020
2019

2025.07.01

Adagene announces up to $25 million strategic investment from Sanofi

2025.05.27

Adagene to Present at Jefferies Global Healthcare Conference 2025

2025.05.22

Adagene Announces Updated Data from Phase 1b/2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at the American Society of Clinical Oncology (ASCO) Annual Meeting

2025.04.28

Adagene Appoints John Maraganore, Ph.D. as Executive Advisor

2025.04.23

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Next page
Last page

Displaying 11 - 15 of 23

Shareholder Tools

© 2026 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn